English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 27 October 2023, 21:00 HKT/SGT
Share:
    

Source: EW Healthcare Partners
EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine

LONDON, Oct 27, 2023 - (ACN Newswire) - EW Healthcare Partners announced that it has acquired a c. 25% minority stake in Boiron Developpement, an entity formed for the purposes of launching a tender offer for the Boiron Group, in partnership with the Boiron Family, at a c. €875 million enterprise value. As part of this transaction, the Boiron family has transferred its 70% stake in the Boiron Group to Boiron Developpement, together with the Boiron employee fund for c. 5% of the capital.

Boiron is a French pharmaceutical company focused on natural medicine, founded in 1932 by pharmacists Jean and Henri Boiron. The company is built around homeopathy and has spearheaded the industry's global development.

Boiron today is the global market leader in homeopathy and a leading global player in natural medicines, with 2022 revenues of €534M. The company offers a diversified portfolio of natural, innovative, science-based, and personalized pharmaceutical products. Over 50% of Boiron's sales are realized outside of France. Boiron benefits from an integrated value chain from registration to distribution, including in-house manufacturing, with the company currently present in 50 countries globally through 23 subsidiaries and 30 distributors. Boiron has also established a strong footprint in the U.S. with €120M in U.S. revenue, with a large portion of products sold through the e-commerce channel.

EW Healthcare Partners is excited to partner with the Boiron family to help further accelerate the company's growth, by expanding the company's offering into additional healthcare verticals and capitalising on the existing platform to launch additional products, in particular in the U.S.

About EW Healthcare Partners ("EW")

With over $2 billion of capital raised since 2014, EW Healthcare Partners seeks to make growth equity investments in fast-growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe. EW Healthcare Partners has a singular commitment to the healthcare industry and has been a long-term investor in numerous healthcare companies, ranging across sectors, stages and geographies. The team of senior investment professionals, operating partners and advisors is based in New York, London and Houston. https://www.ewhealthcare.com

Contact Information

Anne DeMaret, Investor Relations, ademaret@ewhealthcare.com (281) 528-1956



Topic: Press release summary
Source: EW Healthcare Partners

Sectors: BioTech, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
TransNusa Focuses on Organic Growth to Strengthen Network Connectivity in China  
Aug 11, 2025 23:55 HKT/SGT
Campaign to promote Hong Kong's advantages in professional services in Vietnam  
Aug 11, 2025 22:46 HKT/SGT
Shoucheng-Backed Data Center REITs Surge on Market Debut  
Aug 11, 2025 22:43 HKT/SGT
31 Concept to Debut Patent-Pending Technology at ISS Asia 2025 in Singapore  
Aug 11, 2025 22:42 HKT/SGT
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan  
Aug 11, 2025 22:39 HKT/SGT
Singapore's Digital Finance Model in Focus at the BFSI IT Summit - Singapore 2025  
Aug 11, 2025 18:26 HKT/SGT
WRC 2025: Shoucheng Showcases Full Robotics Value Chain  
Aug 11, 2025 16:27 HKT/SGT
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products  
Aug 11, 2025 10:41 HKT/SGT
Natural Beauty 2025 Interim Profit Surges by 136% to HK$11 Million  
Aug 11, 2025 08:15 HKT/SGT
Saudi Electricity Company Reports 22% Net Profit Growth in Q2 2025  
Aug 11, 2025 06:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575